Abstract:Background: Hybrid molecules combining uracil skeleton with methylidene exo-cyclic group were designed in the search for novel anticancer drug candidates. Objective: Two series of racemic 5-methylidenedihydrouracils, either 1,3-disubstituted or 1,3,6-trisubstituted were synthesized and tested for their possible cytotoxic activity against two cancer cell lines (HL-60 and MCF-7) and two healthy cell lines (HUVEC and MCF-10A). The most cytotoxic analogs were re-synthesized as pure enantiomers. The analog designated as U-332 [(R)-3-(4-bromophenyl)-1-ethyl-5-methylidene-6-phenyldihydrouracil], which had a very low IC50 value in HL-60 cell line (0.77μM) and was the most selective towards cancer cells was chosen for further experiments on HL-60 cell line, in order to determine the possible mechanism involved in its antineoplastic action. Methods: Cytotoxic activities of compound was assessed by the MTT assay. In order to explore the mechanism of U-332 activity, we performed quantitative real-time PCR analysis of p53 and p21 genes. Apoptosis, cell proliferation and DNA damage in HL-60 cells were determined using the flow cytometry. The ability of U-332 to determine GADD45ɑ protein level in HL-60 cells incubated with U-332 was analyzed by ELISA test. Results: U-332 was shown to generate excessive DNA damage (70% of the cell population), leading to p53 activation, resulting in p21 down-regulation and a significant increase of GADD45α protein, responsible for the cell cycle arrest in G2/M phase. Conclusion: U-332 can be used as a potential lead compound in the further development of novel uracil analogs as anticancer agents.

Conjugation of Uridine with Oleanolic Acid Derivatives As Potential Antitumor Agents.

Synthesis and cytotoxic evaluation of several oleanolic acid–uracil/thymine conjugates

Design, Synthesis, and Anticancer Activity Evaluation of Hybrids of Azoles and Barbituric Acids.

Ursolic Acid Conjugates: A New Frontier in Anticancer Drug Development

Synthesis and Biological Evaluation of Novel Ursolic acid Derivatives as Potential Anticancer Prodrugs

Synthesis and Antitumor Activity of 2-Aryl-1, 2, 4-Triazolo[1, 5-A] Pyridine Derivatives

Synthesis of Oleanolic Acid-Dithiocarbamate Conjugates and Evaluation of Their Broad-Spectrum Antitumor Activities

The Synthesis of Ursolic Acid Derivatives with Cytotoxic Activity and the Investigation of Their Preliminary Mechanism of Action.

Design, Synthesis, and Biological Evaluation of Novel Nitrogen Heterocycle-Containing Ursolic Acid Analogs as Antitumor Agents

Design, Syntheses, and Antitumor Activity of Novel Chromone and Aurone Derivatives.

Excellent antitumor and antimetastatic activities based on novel coumarin/pyrazole oxime hybrids

Synthesis and Biological Evaluation of a Novel Class of Coumarin Derivatives.

Novel uracil derivatives as anti-cancer agents: Design, synthesis, biological evaluation and computational studies

Design, synthesis, and antitumor evaluation of trimethoxyflavonoid with arylurea structure against hepatocellular carcinoma

Design, synthesis and biological evaluation of hybrid of ubenimex-fluorouracil for hepatocellular carcinoma therapy

Synthesis, and discovery of a potential anti-HepG2 agents: coumarin derivatives containing 3-Aryl isoxazolyl moiety

Design and synthesis of novel ureido and thioureido conjugated hydrazone derivatives with potent anticancer activity

Design, synthesis and biological evaluation of fluorescent derivatives of ursolic acid in living cells

Design, synthesis, and antitumor activity of oleanolic acid derivatives

New Uracil Analogs with Exocyclic Methylidene Group as Potential Anticancer Agents

Design, Synthesis and Evaluation of Novel Diaryl Urea Derivatives As Potential Antitumor Agents.